Translational pharmaceuticals in retinal disease
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
This video has been archived as it is more than 2 years old. CPD is no longer available.
Kevin Gregory-Evans examines new approaches to treating common retinal diseases, explaining both research and testing. He encourages the development of new therapeutics in order to stop the most common cause of blindness.
This lecture was part of an event called "The Lang lecture: Professor Kevin Gregory-Evans supported by J.E.J White” at The Royal Society of Medicine in London.
Date of lecture: 10th October 2013
This video is available for iPad via Safari
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- The CPD process for this video has now expired. Previously booked CPD credits can still be accessed after login.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.